All posts by: Michael Zand

About Michael Zand

Global and USA Cancer Immunotherapy Market 2017-2022: This Space will be a Significant Revenue Generator … – PR Newswire (press release)

Continue reading

2018-03-07 NEWS

Global and USA Cancer Immunotherapy Market 2017-2022: This Space will be a Significant Revenue Generator …
PR Newswire (press release)
reveals that the cancer immunotherapy space will be a significant revenue generator (excess of $80 billion) for the biopharmaceutical industry by 2020. The market has been supported by the approval of Bristol-Myers’ Yervoy drug for melanoma, BMS’s

Continue reading

2018-03-07 NEWS

2018 is a big year for gene editing. Here’s what to watch for locally.
Boston Business Journal
Is CRISPR, the experimental gene editing technique that’s taken the biotech world by storm, ready for prime time? A handful of local companies and their investors are about to find out. This year is shaping up to be a potentially transformative one for

Continue reading

2018-03-07 NEWS

On the immortality of stem cells
Science Daily
Human embryonic stem cells are considered to be immortal: they do not age, they can proliferate indefinitely, and form any tissue of the organism. As such, they do not accumulate damaged proteins like the ones related with diseases such as Alzheimer’s

and more »

Continue reading

2018-03-07 NEWS

WebMD

Stem Cell Clinics Sell Bogus ‘Cures’ for Knee Pain
WebMD
WEDNESDAY, March 7, 2018 (HealthDay News) — Stem cell clinics are charging big money for knee arthritis “cures” and making extravagant claims about their therapies, a new study contends. A same-day injection for one knee costs thousands of dollars at

and more »